We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Journées Internationales de Biologie 2006

By Labmedica staff writers
Posted on 22 Dec 2006
The annual Journées Internationales de Biologie (JIB) was held November 7-10, 2006, in Paris (France) under the auspices of the French Ministère de la Santé et des Solidarités and the Caisse Nationale d'Assurance Maladie (CNAM). More...


This annual clinical biology meeting in Europe combined an expanding trade show with 165 confirmed exhibitors and a high-level scientific program that focused on state-of-the-art and current practices in the medical laboratory. Aimed at biologists in both the private and hospital sectors, biomedical engineers, technicians, and hospital physicians, JIB provided extensive and comprehensive information on progress and technical advances in clinical biology.

Tunisia was the invited guest country at the JIB 2006, succeeding Belgium, Spain, Portugal, and Italy. The opening ceremony of the exhibition was held at the Tunisian pavilion, the "Médina Ibn Khaldoun” in the presence of Dr. Mohamed Ridha Kechrid, minister of health of Tunisia, Tijani Haddad, minister of tourism of Tunisia, and Mohamed Raouf Najar, ambassador of Tunisia in Paris. During the opening address, Dr. Mohamed Ridha Kechrid underlined the strong links that have been established between France and Tunisia's biologists, giving as an example the successful collaboration of the "Bio Quality Tunisia.”

The "Scientific Day of Tunisia” retraced the history of medicine and biology in Tunisia and highlighted the medical specificities of the country. It also focused on the quality system at the National Blood Transfusion Center in Tunisia, and gave insight into gastric pathologies and Helicobacter pylori infections, as well as hemoglobinopathies in Tunisia.

This year, the scientific panel, traditionally composed of the Journées Biologiques de Lariboisière, the Société Française de Biologie Clinique (SFBC), and L'institut Nationale de la Santé et de la Recherche Médicale (INSERM), also consisted of the Journées de Internat des Hôpitaux de Paris (JIPPIF), the Société Française Vitamines et Biofacteurs (SFVB), and the Société Francophone d'Etude et de Recherche sur les Eléments Toxiques et Essentiels (SFERETE).

The scientific program, which consisted of 12 sessions, about 100 speakers, and 130 poster sessions, was attended by over 1,600 delegates. It offered a unique opportunity to become acquainted with state-of-the-art information about rare diseases. New subjects that are likely to influence future practices in biologic investigations, such as molecular imaging and apoptosis as well as more classical aspects of biology, were discussed.



Related Links:
Journées Internationales de Biologie

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Staining System
RAL DIFF-QUIK
New
Pan-Cancer Panel
TruSight Oncology 500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The discovery of early markers for ovarian cancer that would have improved sensitivity could aid detection (Photo courtesy of Adobe Stock)

Highly Accurate Biomarkers Could Detect Ovarian Cancer Before Clinical Diagnosis

Ovarian cancer is a deadly and challenging disease, primarily because early detection is difficult. Most women (70-75%) are diagnosed only after the cancer has already spread, which significantly reduces... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.